Search

Your search keyword '"Braunwald, Eugene"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Braunwald, Eugene" Remove constraint Author: "Braunwald, Eugene" Journal american journal of cardiology Remove constraint Journal: american journal of cardiology
109 results on '"Braunwald, Eugene"'

Search Results

1. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial)

2. Comparison of patients with <60% to >-60% diameter narrowing of the myocardial infarct-related artery after thrombolysis

3. Use of composite endpoints in thrombolysis trials of acute myocardial infarction

4. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina

5. Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients

6. Anticoagulant effects of Hirulog, a novel thrombin inhibitor, in patients with coronary artery disease

8. Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II study

9. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator

10. Rationale, design and baseline characteristics of the Survival and Ventricular Enlargement trial

11. Patency of the infarct-related coronary artery and ventricular geometry

12. Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management

13. Ventricular enlargement following infarction is a modifiable process

14. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction

15. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator

21. Thomas W. Smith 1936-1997.

22. Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50).

23. Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non–ST-Segment Elevation Acute Coronary Syndrome (from the MERLIN-TIMI 36 Trial)

24. Opposing Effects of β Blockers and Angiotensin-Converting Enzyme Inhibitors on Development of New-Onset Diabetes Mellitus in Patients With Stable Coronary Artery Disease

26. Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).

27. Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies

28. Risk of All-Cause Mortality, Recurrent Myocardial Infarction, and Heart Failure Hospitalization Associated With Smoking Status Following Myocardial Infarction With Left Ventricular Dysfunction

29. Pleiotropic Effect of Lovastatin, With and Without Cholestyramine, in the Post Coronary Artery Bypass Graft (Post CABG) Trial

30. Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)

31. Relation of Hyperemic Epicardial Flow to Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy

32. Effect of Intensive Lipid-Lowering Therapy on Mortality After Acute Coronary Syndrome (a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Trials)

33. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III Algorithm for Selecting Candidates for Statin Therapy: Insights from the A to Z Trial

34. Association of Platelet Counts on Presentation and Clinical Outcomes in ST-Elevation Myocardial Infarction (from the TIMI Trials)

35. Association Between Blood Glucose and Long-Term Mortality in Patients With Acute Coronary Syndromes in the OPUS-TIMI 16 Trial

36. C-Reactive Protein and Cardiovascular Outcomes in Smokers Versus Nonsmokers in Non–ST-Elevation Acute Coronary Syndrome (from the TACTICS-TIMI 18 Trial)

37. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy

38. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction

39. Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction

40. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction

41. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries

42. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion

43. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction

45. Prognosis in the Thrombolysis in Myocardial Ischemia III Registry according to the Braunwald unstable angina pectoris classification

46. Seasonal variation of myocardial infarct size.

47. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience).

48. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.

49. The Platelet PI[sup A2] and Angiotensin-Converting Enzyme (ACE) D Allele Polymorphisms and the Risk of Recurrent Events After Acute Myocardial Infarction.

50. A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.

Catalog

Books, media, physical & digital resources